Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease
暂无分享,去创建一个
H. Kantarjian | P. Allen | L. Medeiros | S. Faderl | B. Dabaja | V. Reed | A. Mazloom | S. Pierce | M. Hadziahmetovic | L. Ballas | F. Shihadeh
[1] J. Bennett,et al. B-Lymphoblastic Leukemia/Lymphoma , 2014 .
[2] R. Storb,et al. Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement. , 2011, International journal of radiation oncology, biology, physics.
[3] D. Johnston,et al. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: A Children's Oncology Group study , 2010, Pediatric blood & cancer.
[4] H. Kantarjian,et al. Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy. , 2009, Blood.
[5] J. Downing,et al. Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1 , 2009, Leukemia.
[6] T. Naoe,et al. Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival rates. , 2007, Leukemia research.
[7] J. P. Meza-Espinoza,et al. Use of the International System for Human Cytogenetic Nomenclature (ISCN). , 2006, Blood.
[8] D. Johnston,et al. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Hong Chang,et al. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. , 2004, Leukemia research.
[10] G. Gatta,et al. Adult acute lymphoblastic leukaemia. , 2004, Critical reviews in oncology/hematology.
[11] C. Pui. Toward optimal central nervous system-directed treatment in childhood acute lymphoblastic leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] M. Höglund,et al. Acute myeloid leukemia with inv(16)(p13q22): Involvement of cervical lymph nodes and tonsils is common and may be a negative prognostic sign , 2002, American journal of hematology.
[13] C. Bloomfield,et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). , 2002, Blood.
[14] D. Hoelzer,et al. Recent approaches in acute lymphoblastic leukemia in adults. , 2000, Reviews in clinical and experimental hematology.
[15] K Wheatley,et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.
[16] C. Bloomfield,et al. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. , 1998, Cancer research.
[17] M. Tribalto,et al. Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia. , 1993, Cancer genetics and cytogenetics.
[18] C. Bloomfield,et al. Central nervous system involvement in acute nonlymphocytic leukemia. A prospective study of adults in remission. , 1987, The American journal of medicine.
[19] R. Larson,et al. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. , 1986, Blood.
[20] A. Cork,et al. A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). , 1985, Blood.
[21] C. Bloomfield,et al. Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.
[22] A. Cork,et al. Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia. , 1979, Blood.
[23] Y. Bertrand,et al. Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group study 58881. , 2011, European journal of cancer.
[24] L. Shaffer,et al. Comprar ISCN 2009 - An International System for Human Cytogenetic Nomenclature | Marilyn L. Slovak | 9783805589857 | Karger AG , 2009 .
[25] M. Slovak,et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. , 2000, Blood.
[26] P. Bolufer,et al. Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement. , 2000, Haematologica.
[27] C. Bloomfield,et al. Fourth International Workshop on Chromosomes in Leukemia 1982: Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.